CAMP4 Therapeutics Corp. (CAMP)
4.60
+0.95
(+26.03%)
USD |
NASDAQ |
Dec 09, 16:00
4.42
-0.18
(-3.91%)
After-Hours: 20:00
CAMP4 Therapeutics EPS Diluted (Quarterly): -0.5536 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TransMedics Group, Inc. | 0.6601 |
| Neumora Therapeutics, Inc. | -0.3507 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.10M |
| Revenue (Quarterly) | 0.795M |
| Total Expenses (Quarterly) | 15.89M |
| Enterprise Value | 146.74M |
| Gross Profit Margin (Quarterly) | 47.67% |
| Profit Margin (Quarterly) | -1.90K% |
| Earnings Yield | -53.35% |
| Normalized Earnings Yield | -52.07 |